|
|
|
News
|
D-Pharm Ltd.
|
|
10-08-2010
|
|
D-Pharm Receives Top-line Results From Cardiac Safety Study with DP-b99
|
|
|
OrSense Ltd.
|
|
29-06-2010
|
|
OrSense Presents Non-Invasive Hemoglobin Monitoring System for Anemia Monitoring, Hemorrhage Detection and Pre-Donation Screening
|
|
|
Gamida Cell Ltd.
|
|
21-06-2010
|
|
The Gamida Cell-TEVA Joint Venture Receives FDA Fast Track Designation for StemEx® for Leukemia and Lymphoma
|
|
|
NiTi Surgical Solutions
|
|
13-05-2010
|
|
NiTi Surgical Solutions Announces Application Milestone and Clinical Data Supporting Lead Product ColonRing as Safe Alternative to Surgical Staples
|
|
|
OrSense Ltd.
|
|
23-03-2010
|
|
OrSense Ltd. Receives U.S. FDA Approval for NMB-200MP Non-Invasive Oximetry Monitoring System
|
|
|
Gamida Cell Ltd.
|
|
10-02-2010
|
|
Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx®, a Cord Blood Stem Cell Product, for Leukemia and Lymphoma.
StemEx study is enrolling patients at cord blood transplant centers in the U.S., Spain, Italy, Hungary and Israel.
|
|
|
Gamida Cell Ltd.
|
|
18-01-2010
|
|
European Medicines Agency (EMA) Waives Requirement to Test StemEx® in Paediatric Patients 17 Years of Age and Under
|
|
|
D-Pharm Ltd.
|
|
31-12-2009
|
|
D-Pharm (DPRM: TASE) Announces Enrollment of First Patient in DP-b99 Phase III Efficacy Study, MACSI
|
|
|
Optonol Ltd.
|
|
14-12-2009
|
|
Alcon to Enter Surgical Glaucoma Market by Acquiring Optonol
|
|
|
Gamida Cell Ltd.
|
|
02-12-2009
|
|
Gamida Cell Announces Feasibility Study with Weill Cornell Medical College
Study is testing a new method to deliver gene correction cells to treat congenital conditions such as Cooley's Anemia
|
|
|
|
|